6 results on '"Magis-Escurra C"'
Search Results
2. Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019.
- Author
-
de Vries G, Akkerman O, Boeree M, van Hest R, Kamst M, de Lange W, Magis-Escurra C, Meijer W, and van Soolingen D
- Subjects
- Humans, Female, Rifampin therapeutic use, Rifampin pharmacology, Antitubercular Agents pharmacology, Netherlands epidemiology, Tuberculosis, Multidrug-Resistant diagnosis, Tuberculosis, Multidrug-Resistant drug therapy, Tuberculosis, Multidrug-Resistant epidemiology, Tuberculosis, Pulmonary diagnosis, Mycobacterium tuberculosis genetics
- Abstract
BACKGROUND: New tools for diagnosis and treatment of rifampicin-resistant (RR-) and multidrug-resistant (MDR-) TB have become available in the last decade, including better tests confirming transmission. OBJECTIVE: To analyse transmission risks of MDR/RR-TB in the Netherlands. METHODS: Analysis of national data of patients with MDR/RR-TB notified in 2010-2019, including contact investigation and genotyping data. RESULTS: Patients with MDR/RR-TB ( n = 121) were more often female (adjusted odds ratio [aOR] 1.5), foreign-born, previously treated for TB (aOR 5.2) and co-infected with HIV (aOR 2.3) than patients with no MDR/RR-TB. Treatment outcomes were satisfactory, with at least 79% completing treatment. After additional whole-genome sequencing (WGS), five molecular clusters of 16 patients remained. Patients in three clusters could not be epidemiologically linked and were unlikely to have been infected in the Netherlands. The remaining eight (6.6%) patients with MDR/RR-TB belonged to two clusters, and were likely the result of transmission in the Netherlands. Among close contacts of patients with smear-positive pulmonary MDR/RR-TB, 13.4% ( n = 38) had TB infection and 1.1% ( n = 3) had TB disease. Only six contacts with TB infection were treated with a quinolone-based preventive treatment regimen. CONCLUSION: MDR/RR-TB is effectively controlled in the Netherlands. Preventive treatment options could be considered more frequently in contacts clearly infected by an index patient with MDR-TB.
- Published
- 2023
- Full Text
- View/download PDF
3. A case promoting use of ultrasound-guided sampling techniques to correctly diagnose MDR-TB in children.
- Author
-
van Aerde KJ, van der Heijden EHFM, Henriet SS, Merkus PJ, Magis-Escurra C, Hoefsloot W, van Ingen J, and van der Flier M
- Subjects
- Bronchoscopes, Child, Endoscopic Ultrasound-Guided Fine Needle Aspiration instrumentation, Humans, Male, Endoscopic Ultrasound-Guided Fine Needle Aspiration methods, Tuberculosis, Multidrug-Resistant diagnosis
- Abstract
A paediatric case of multidrug-resistant tuberculosis in which endo-oesophageal ultrasound-guided fine-needle aspiration using an endobronchial ultrasound-guided bronchoscope was used to collect a sample for microbial analyses is presented. In our experience, ultrasound-guided sampling techniques, both endo-oesophageal and endobronchial, can be safely used for the diagnosis of paediatric intrathoracic tuberculous lymphadenopathy in children aged 3 years. Interventional pulmonologists with experience in using these techniques should be part of the multidisciplinary team treating these patients.
- Published
- 2019
- Full Text
- View/download PDF
4. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
- Author
-
van Altena R, de Vries G, Haar CH, de Lange WC, Magis-Escurra C, van den Hof S, van Soolingen D, Boeree MJ, and van der Werf TS
- Subjects
- Adolescent, Adult, Age Distribution, Child, Child, Preschool, Coinfection therapy, Drug Therapy, Combination, Female, Follow-Up Studies, HIV Infections therapy, Humans, Infant, Infant, Newborn, Male, Middle Aged, Netherlands epidemiology, Retrospective Studies, Risk Factors, Sex Distribution, Treatment Outcome, Young Adult, Antitubercular Agents therapeutic use, Mycobacterium tuberculosis drug effects, Tuberculosis, Multidrug-Resistant epidemiology, Tuberculosis, Multidrug-Resistant therapy, Tuberculosis, Pulmonary therapy
- Abstract
Setting: Resistance to the two key anti-tuberculosis drugs isoniazid and rifampicin is a characteristic of multidrug-resistant tuberculosis (MDR-TB). MDR-TB is a scourge requiring toxic, prolonged treatment and is associated with poor outcomes. The Netherlands is a country with a long-standing, integrated, well-resourced TB service where all patients are offered culture-confirmed diagnosis by a central reference laboratory., Objective: To assess the treatment outcomes of MDR-TB patients over a period of 10 years in The Netherlands., Design: Demographic, clinical and microbiological features of all patients with MDR-TB who started treatment in 2000-2009 in the Netherlands were analysed from national registry and patient records., Results: Characteristics of the 113 MDR-TB patients were as follows: male/female ratio 1.57, 96% foreign born, median age 29 years, 96 (85%) pulmonary TB, 56 (50%) smear-positive, 14 (12%) human immunodeficiency virus (HIV) co-infected. Of the 104 (92%) patients who started MDR-TB treatment, 86% had a successful outcome using a median of six active drugs; eight underwent pulmonary surgery. HIV negativity was associated with successful outcome (adjusted OR 2.1, 95%CI 1.1-3.8)., Conclusion: High success rates for MDR-TB treatment were achieved with close collaboration of all stakeholders, reaching the targets set for drug-susceptible TB. HIV remained an independent risk factor for unsuccessful treatment outcome.
- Published
- 2015
- Full Text
- View/download PDF
5. The Cough Cylinder: a tool to study measures against airborne spread of (myco-) bacteria.
- Author
-
Vanden Driessche K, Marais BJ, Wattenberg M, Magis-Escurra C, Reijers M, Tuinman IL, Boeree MJ, van Soolingen D, de Groot R, and Cotton MF
- Subjects
- Adult, Aged, Bacteriological Techniques instrumentation, Equipment Design, Female, Humans, Male, Middle Aged, Young Adult, Air Microbiology, Bacteria isolation & purification, Cough microbiology, Mycobacterium tuberculosis isolation & purification
- Abstract
Background: 'Covering your cough' reduces droplet number, but its effect on airborne pathogen transmission is less clear. The World Health Organization specifically recommends cough etiquette to prevent the spread of Mycobacterium tuberculosis, but implementation is generally poor and evidence supporting its value is lacking., Methods: We constructed a model to assess 'real life' transmission risk by counting viable pathogens from aerosols produced by coughing patients, thus allowing the assessment of outward protection measures in a standardised fashion. During the validation process, we focused on rod-shaped bacteria as surrogates for M. tuberculosis., Results: The Cough Cylinder enabled us to sample Pseudomonas aeruginosa, Escherichia coli and mycobacteria from aerosols produced by patients with cystic fibrosis, primary ciliary dyskinesia and tuberculosis. Pathogens in droplets and in airborne particles could be sampled. Delayed air sampling allowed specific measurement of persistent airborne particles., Conclusion: This novel experimental system allows measurement of aerosol pathogen spread in a highly standardised fashion. It also offers the possibility to assess the impact of different interventions to limit aerosol transmission.
- Published
- 2013
- Full Text
- View/download PDF
6. Surgical treatment of non-tuberculous mycobacterial lung disease: strike in time.
- Author
-
van Ingen J, Verhagen AF, Dekhuijzen PN, van Soolingen D, Magis-Escurra C, Boeree MJ, and de Lange WC
- Subjects
- Adult, Female, Follow-Up Studies, Humans, Lung Diseases microbiology, Male, Middle Aged, Mycobacterium Infections microbiology, Mycobacterium avium isolation & purification, Netherlands, Patient Selection, Pneumonectomy methods, Recurrence, Retrospective Studies, Time Factors, Lung Diseases surgery, Mycobacterium isolation & purification, Mycobacterium Infections surgery
- Abstract
Setting: The Netherlands., Objective: To describe our experiences with the adjunctive role and benefits of surgery for lung disease due to non-tuberculous mycobacteria (NTM), specifically addressing its indications and timing., Design: Retrospective medical file review of eight patients who underwent surgical treatment for NTM lung disease in the period January 2000 to January 2009, and review of the available literature., Results: Therapy-resistant cavitary NTM disease was the most frequent indication for surgery; two patients underwent pneumonectomy for an infected destroyed lung. Mycobacterium avium was the most common causative agent. Surgery resulted in culture conversion in seven patients; one patient died 2 months after pneumonectomy. No relapses have been noted in the other seven after an average of 19 months of follow-up., Conclusions: Adjunctive surgical treatment for NTM lung disease yields encouraging results, similar to previously published case series. Careful patient selection, based on extent and type of disease as well as on cardiopulmonary fitness, is important. Potential benefits of surgery should be considered for every individual patient in whom NTM lung disease is diagnosed and re-evaluated after 6 months of treatment. Where possible, surgery should be pursued and conducted in a timely fashion.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.